503B Recordkeeping; AERs

Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act

503B Adverse Event Reporting Guidance

503B Recordkeeping; AERs

OMB: 0910-0800

Document [file]
Download: file | pdf
File Typeinode/x-empty

© 2024 OMB.report | Privacy Policy